Product Information
CEFACLOR 250 MG CAPSULE is a generic product labeled by Carlsbad Technology Inc., priced at $0.9323 per EA under NDC 61442017130. Its NADAC has been published 587 times since Nov 28, 2013.
FDA first approved this application on Jan 22, 2004.
Strength
250 mg/1
Manufacturer
Carlsbad Technology Inc.NDC
61442017130
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CEFACLORApproval Type
Generic (ANDA)
FDA Application
ANDA065146FDA Approved
1/22/2004
On Market Since
7/31/2008
Pharmacological Classes
Price Statistics
The NADAC for CEFACLOR 250 MG CAPSULE has been published 587 times since Nov 28, 2013, and over the history we have for it it has declined 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9323 per EA |
|---|---|
| All-time high | $1.5961 (Jan 15, 2014) |
| All-time low | $0.6037 (Oct 23, 2024) |
| 52-week high | $0.9468 |
| 52-week low | $0.8733 |
| Median price | $1.0896 |
| Average price | $1.0608 |
| Largest weekly change | +59.1% (Nov 20, 2024) |
| Weeks tracked | 587 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cefaclor market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Carlsbad Technology Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefaclor market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFACLOR 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CEFACLOR 250 MG CAPSULE, manufactured by Carlsbad Technology Inc., is $0.9323 per EA (NDC 61442017130), effective Sep 30, 2026.
How has the price of CEFACLOR 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CEFACLOR 250 MG CAPSULE has declined 30.1%. It has been tracked across 587 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFACLOR 250 MG CAPSULE?
Since Nov 28, 2013, the NADAC for CEFACLOR 250 MG CAPSULE has ranged from a low of $0.6037 (Oct 23, 2024) to a high of $1.5961 (Jan 15, 2014), with a median of $1.0896 per EA.
Are there cheaper alternatives to CEFACLOR 250 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CEFACLOR 250 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CEFACLOR 250 MG CAPSULE?
CEFACLOR 250 MG CAPSULE (NDC 61442017130) is labeled by Carlsbad Technology Inc., and CMS classifies it as a generic product.